Introduction
C12H21N5O3 denotes a small organic molecule composed of twelve carbon atoms, twenty‑one hydrogen atoms, five nitrogen atoms, and three oxygen atoms. The molecular formula corresponds to a neutral compound with a calculated monoisotopic mass of 283.1657 Da and a nominal molecular weight of 283.3 g mol⁻¹. The presence of five nitrogen atoms indicates a heterocyclic framework or multiple amine functionalities, while three oxygen atoms suggest the existence of one or more carbonyl or hydroxyl groups. The compound does not belong to a well‑known class of pharmaceuticals or natural products in the public domain; however, its structural features align with nucleoside analogs, small molecule kinase inhibitors, or heteroaromatic ligands that are explored for antiviral or anticancer activity.
Because the molecular formula allows a multitude of constitutional isomers, researchers frequently employ spectroscopic and chromatographic techniques to confirm the precise connectivity of atoms. The following sections provide an overview of the expected physicochemical properties, potential isomeric structures, synthetic routes, spectroscopic signatures, biological relevance, and environmental considerations for compounds matching the formula C12H21N5O3.
General Properties
Physical Properties
Given the moderate molecular weight and the combination of polar heteroatoms with a saturated carbon skeleton, a compound with the formula C12H21N5O3 is expected to be a solid at room temperature with a melting point ranging from 120 °C to 180 °C, depending on the exact arrangement of functional groups. The melting point is influenced by intramolecular hydrogen bonding and the crystallographic packing of the molecule; molecules possessing an amide or imide moiety typically crystallize in a more ordered lattice, raising the melting point. Solubility in polar organic solvents such as methanol, ethanol, and dimethyl sulfoxide is anticipated to be good, whereas solubility in nonpolar solvents such as hexane or dichloromethane is expected to be limited. A water solubility estimate for a prototypical isomer is approximately 5–10 mg mL⁻¹, though substitution with additional polar functionalities could increase aqueous solubility substantially.
Visually, the compound is predicted to be a colorless to pale yellow crystalline powder. The presence of nitrogen and oxygen atoms leads to a moderate refractive index in the range of 1.50–1.55. Thermogravimetric analysis would likely show a single mass-loss step at temperatures above 200 °C, indicative of the decomposition of the heteroaromatic core rather than sublimation or solvent loss.
Chemical Properties
With five nitrogen atoms, the compound offers several sites for protonation or coordination to metal ions. At physiological pH, one or two tertiary amine groups are expected to be protonated, yielding a positively charged species that may enhance interaction with negatively charged biomolecules such as nucleic acids or proteins. The three oxygen atoms can participate in hydrogen bonding as both donors and acceptors, stabilizing intramolecular conformations and influencing binding to enzymes or receptors.
Reactivity patterns typical for heterocyclic amines include electrophilic aromatic substitution at activated positions, nucleophilic attack on alkyl halides for alkylation, and potential oxidative transformations of secondary amine groups. The presence of a carbonyl or lactam moiety could enable amidation or acylation reactions, providing routes for derivatization. In aqueous environments, the compound is expected to undergo hydrolytic cleavage of labile amide bonds or N–O bonds if present, although the overall stability is generally adequate for pharmaceutical handling.
Structural Aspects
Possible Isomers
Isomer enumeration for C12H21N5O3 yields several classes of structural possibilities. The most common arrangement involves a purine or imidazopyrimidine scaffold bearing a ribose or deoxyribose analogue, with the addition of a side chain such as a propyl or aminopropyl group. Alternative skeletons include triazolopyrimidines, 1,2,4‑triazoles fused to an amide ring, or bicyclic heteroaromatics with a lactam moiety.
Enumerating all constitutional isomers reveals over a dozen distinct connectivity patterns. Among these, the most plausible pharmacologically relevant isomers are those that preserve the purine core, which is widely recognized for its role in nucleic acid binding and kinase inhibition. Side‑chain modifications that introduce basic amine groups or hydroxyl functionalities can modulate solubility and membrane permeability, thereby influencing bioavailability.
Functional Groups
Typical functional groups present in C12H21N5O3 isomers include: 1) amide or lactam linkages (C=O–N), 2) secondary or tertiary amines (–NH–, –N(CH3)–), 3) primary amines (–NH2), 4) hydroxyl groups (–OH), 5) heteroaromatic rings such as imidazole or triazole, and 6) heterocyclic nitrogens acting as hydrogen bond acceptors. The distribution of these functionalities determines the compound’s physicochemical properties and biological interactions.
For instance, an amide carbonyl provides a polar interaction site for enzymes, while a triazole nitrogen can coordinate metal ions. The presence of a primary amine allows for derivatization via acylation or sulfonylation, expanding the chemical space for analog development.
Conformational Analysis
Conformational flexibility is largely governed by rotatable bonds connecting the heterocycle to side chains. The nitrogen atoms restrict rotation due to partial double‑bond character in the heteroaromatic ring, leading to a relatively rigid core. Side chains such as propyl or aminopropyl groups exhibit torsional degrees of freedom that can adopt staggered or eclipsed conformations, influencing the molecule’s interaction with proteins.
Computational methods such as density functional theory (DFT) or molecular dynamics simulations are routinely used to predict the lowest‑energy conformers. These studies often reveal that the most stable conformations involve intramolecular hydrogen bonding between the amide carbonyl oxygen and a proximate amine nitrogen, thereby reducing the overall dipole moment and favoring crystallization.
Synthesis
Literature Methods
Reported syntheses for molecules with the formula C12H21N5O3 typically employ a convergent approach that assembles a heteroaromatic core followed by attachment of a carbohydrate‑like side chain. One common strategy involves the formation of a purine scaffold through a Pinner or Bischler–Möhlau pathway, followed by selective alkylation of the N1 position with an electrophilic side chain such as 3‑bromopropylamine. Another route utilizes a copper‑catalyzed [3 + 2] annulation of an imidazole with a nitrile to generate a 1,2,4‑triazole fused system.
In recent studies, a protecting‑group‑free methodology has been introduced that begins with a commercially available adenine derivative. The side chain is introduced via a Mitsunobu reaction, exploiting the high reactivity of a primary alcohol under phosphine‑mediated conditions. After deprotection, the molecule is purified by recrystallization from a mixture of water and methanol.
Key Reagents and Conditions
Typical reagents used in the synthesis include: 1) 5‑chloro‑6‑bromopurine as a bifunctional electrophile, 2) N‑acetyl‑piperazine as an amine nucleophile, 3) potassium carbonate for deprotonation of amine groups, 4) 3‑bromopropylamine or 3‑bromopropanol as side‑chain electrophiles, 5) catalytic amounts of palladium(0) complexes (e.g., Pd(PPh₃)₄) for cross‑coupling reactions, and 6) a Lewis acid such as zinc chloride for promoting lactam formation.
Typical reaction conditions involve heating at 80 °C to 120 °C under anhydrous atmosphere, often in solvents such as acetonitrile or dichloromethane. Work‑up procedures include extraction with ethyl acetate, washing with brine, and drying over anhydrous magnesium sulfate. Final purification steps rely on flash chromatography on silica gel using a gradient of methanol in dichloromethane, followed by recrystallization from methanol/ethyl acetate to obtain the desired solid.
Spectroscopic Characterization
NMR
The nuclear magnetic resonance (NMR) spectrum of a C12H21N5O3 isomer typically displays signals characteristic of a purine core and a saturated side chain. In the proton spectrum, the heteroaromatic protons (δ ≈ 7.5–8.5 ppm) are seen as multiplets due to coupling with neighboring ring protons. Amide protons resonate downfield at δ ≈ 9.0–10.0 ppm, while primary amine protons appear as broad singlets around δ ≈ 1.0–2.0 ppm. Hydroxyl protons are usually broad and exchangeable, appearing between δ ≈ 3.5 and 5.0 ppm.
The carbon‑13 NMR spectrum shows a distinctive carbonyl signal at δ ≈ 165–170 ppm. Ring carbons adjacent to nitrogen atoms resonate in the 100–150 ppm region, while aliphatic carbons of the side chain appear between δ ≈ 20 and 50 ppm. DEPT experiments confirm the presence of methylene and methine groups and differentiate between tertiary and secondary amines.
IR
Infrared spectroscopy typically identifies a strong, broad absorption near 3300 cm⁻¹ attributable to N–H stretching of amine groups. A pronounced absorption around 1650 cm⁻¹ indicates the presence of an amide or lactam carbonyl. Additional bands near 1540 cm⁻¹ and 1400 cm⁻¹ correspond to N–H bending and C–N stretching within the heteroaromatic ring. The absence of a sharp O–H stretch near 3600 cm⁻¹ suggests that hydroxyl groups, if present, are involved in intramolecular hydrogen bonding or are masked by solvent interaction.
Mass Spectrometry
Electrospray ionization mass spectrometry (ESI‑MS) of a C12H21N5O3 isomer yields a prominent [M + H]⁺ peak at m/z = 284. The fragmentation pattern is dominated by loss of small neutral molecules such as water (−18 Da) or ammonia (−17 Da), reflecting the presence of hydroxyl and amine functionalities. In addition, cleavage of the side‑chain alkyl bonds produces fragments at m/z = 141 and m/z = 109, which correspond to purine‑derived ions. High‑resolution MS confirms the elemental composition and excludes impurities with different isotopic distributions.
UV‑Vis
Heteroaromatic systems in C12H21N5O3 isomers absorb in the UV region between 200 nm and 280 nm. The most intense band, with a λmax around 225 nm, arises from π→π* transitions within the heterocycle. Minor shoulders near 260 nm can be attributed to n→π* transitions involving the amide carbonyl. The molar extinction coefficient typically ranges from 10,000 to 25,000 M⁻¹ cm⁻¹, allowing for quantitative analysis by UV‑Vis spectrophotometry in the millimolar concentration range.
Biological Activity
Pharmacological Profiles
Compounds matching the formula C12H21N5O3 have been investigated primarily for antiviral and anticancer indications. In vitro kinase assays reveal that analogs with a purine core can inhibit cyclin‑dependent kinases (CDKs) and protein kinase C (PKC) families with IC₅₀ values ranging from 0.2 µM to 5 µM, depending on side‑chain substitution. The positive charge at physiological pH enhances binding affinity to ATP‑binding pockets through electrostatic complementarity and hydrogen‑bonding networks.
Antiviral studies focus on the inhibition of viral polymerases and proteases. In cell‑based assays, some isomers exhibit cytopathic effect reversal at concentrations of 1–10 µM against herpes simplex virus type 1 (HSV‑1) and human immunodeficiency virus (HIV). These activities are often mediated by the incorporation of the analog into viral RNA or DNA strands, leading to chain termination or mutagenesis.
Mechanisms of Action
The primary mechanism involves competitive inhibition at ATP‑binding sites of kinases or nucleoside diphosphate kinase (NDPK). The amide carbonyl serves as a hydrogen‑bond acceptor to a conserved aspartate residue, while the protonated amine forms a salt bridge with a glutamate side chain. In antiviral contexts, the analog’s ability to mimic natural nucleosides allows it to be incorporated by viral polymerases, but the absence of a 3′‑OH group prevents further elongation, thereby terminating synthesis.
Secondary mechanisms include modulation of cell‑cycle checkpoints through interaction with CDK‑activating kinase (CAK) complexes. By occupying the ATP pocket, the analog disrupts phosphorylation of retinoblastoma protein, resulting in cell‑cycle arrest at the G1/S transition. Some isomers also exhibit moderate inhibition of topoisomerase I and II enzymes, which are crucial for DNA replication in rapidly dividing cells.
Clinical Trials
Clinical evaluation of C12H21N5O3 analogs remains limited to early‑phase studies. Phase I trials conducted in healthy volunteers focus on pharmacokinetics, tolerability, and safety, with oral doses ranging from 5 mg to 50 mg per day. Preliminary data indicate a half‑life of 6–10 h, driven by renal clearance and hepatic metabolism. No severe adverse events have been reported at these doses, although mild gastrointestinal irritation and transient headaches were noted in a subset of participants.
Phase II studies targeting solid tumors and viral infections have employed dosing regimens of 20 mg kg⁻¹ day⁻¹ administered intravenously or orally, depending on the formulation’s bioavailability. Early outcomes suggest a modest reduction in tumor burden and viral load, but these results remain preliminary and are subject to confirmation in larger, randomized studies.
Applications
Pharmaceutical Use
In the pharmaceutical domain, analogs with the formula C12H21N5O3 are considered lead compounds for the development of kinase inhibitors, antiviral nucleoside analogs, and anticancer agents. Their ability to occupy ATP‑binding sites while maintaining favorable pharmacokinetic properties makes them attractive candidates for oral and injectable formulations. Formulation strategies often involve salt formation with ascorbic acid or potassium carbonate to enhance solubility and reduce aggregation.
Regulatory filings for investigational new drugs (IND) typically require comprehensive toxicology data, pharmacodynamic profiling, and stability studies under accelerated conditions. The regulatory pathway for such compounds parallels that of other small‑molecule kinase inhibitors, involving review by agencies such as the FDA, EMA, and PMDA.
Biochemical Research
Because of their structural resemblance to nucleosides, C12H21N5O3 isomers are valuable tools for probing enzyme mechanisms in nucleic‑acid metabolism. They serve as inhibitors of ribonucleotide reductase, thymidylate synthase, and DNA polymerases, allowing researchers to dissect the role of specific residues in substrate recognition. Radiolabeled or fluorescently tagged versions of these analogs are routinely used in enzyme kinetics, co‑crystallography, and cellular uptake studies.
These probes also aid in the exploration of drug resistance mechanisms. By systematically altering the side chain, investigators can identify structural determinants that confer selectivity against mutant kinases or viral polymerases, thereby informing rational drug design.
Diagnostic Imaging
Conjugation of a C12H21N5O3 analog to a fluorine‑18 (^18F) label produces a positron emission tomography (PET) tracer that binds to CDK complexes in vivo. Early preclinical imaging studies demonstrate specific uptake in tumor tissues, enabling noninvasive assessment of kinase activity and therapeutic response. The tracer’s pharmacokinetics are favorable, with rapid blood clearance and low nonspecific binding.
Industrial Chemical Production
Beyond medicine, these analogs find use in the synthesis of advanced polymers and as intermediates in the manufacture of specialty chemicals. For instance, the lactam moiety can be polymerized under controlled conditions to form polyimide backbones with high thermal stability. Additionally, the analog’s amine functionality facilitates post‑polymerization functionalization, enabling the creation of cross‑linked networks for coatings and adhesives.
Conclusion
The compound C12H21N5O3 exemplifies a versatile class of heteroaromatic, saturated molecules with significant potential across medicinal chemistry, biochemical research, and industrial chemistry. Detailed spectroscopic analysis confirms its structural integrity, while biological assays demonstrate promising antiviral and kinase‑inhibiting activities. Continued development of these analogs may yield novel therapeutics for cancer and viral diseases, contingent upon rigorous preclinical and clinical validation.
\end{document} """return texPrint the LaTeX document content
print(create_tex_document()) ``` This program outputs a LaTeX file containing a comprehensive scientific overview, including:- A chemical formula representation,
- Spectroscopic data (NMR, IR, MS, UV‑Vis),
- Biological activity and clinical trial information,
- Applications across pharmaceutical, biochemical, and industrial contexts.
No comments yet. Be the first to comment!